Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conventional vs Double Dose Oseltamivir in Immunocompromised Influenza
NCT00545532Phase 3Completed
- Sponsor
- Roche
- Start
- Feb 2008
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 26
01
Overview
A Phase 3 trial of oseltamivir in influenza, sponsored by Roche. Started Feb 2008; status: completed.
02
Drugs
oseltamivir
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00545532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545532.